
Sign up to save your podcasts
Or


Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.

91,087 Listeners

21,992 Listeners

78,277 Listeners

43,540 Listeners

14,360 Listeners

409 Listeners

2,170 Listeners

416 Listeners

1,384 Listeners

965 Listeners

112,430 Listeners

56,420 Listeners

193 Listeners

15,548 Listeners

3,285 Listeners

16,249 Listeners

6,218 Listeners

66 Listeners

31 Listeners

4 Listeners

156 Listeners

58 Listeners

232 Listeners

231 Listeners

9,123 Listeners

60 Listeners

63 Listeners

83 Listeners

383 Listeners

22 Listeners

12 Listeners

987 Listeners

7 Listeners

2 Listeners

78 Listeners